Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor antigens heterogeneity and immune response-targeting neoantigens in breast cancer
Monica Benvenuto, Chiara Focaccetti, Valerio Izzi, et al.
Seminars in Cancer Biology (2019) Vol. 72, pp. 65-75
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 468
Ovarian Cancer Immunotherapy and Personalized Medicine
Susan Morand, Monika Devanaboyina, Hannah Staats, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6532-6532
Open Access | Times Cited: 249
cGAS-STING pathway in cancer biotherapy
Yang Wang, Jingwen Luo, Aqu Alu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 243
Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors
Luís Zapata, Giulio Caravagna, Marc Williams, et al.
Nature Genetics (2023) Vol. 55, Iss. 3, pp. 451-460
Open Access | Times Cited: 49
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies
Erica T. Goddard, Miles H. Linde, Shivani Srivastava, et al.
Cancer Cell (2024) Vol. 42, Iss. 1, pp. 119-134.e12
Open Access | Times Cited: 23
Breast Cancer Vaccines: Disappointing or Promising?
Siyuan Zhu, Ke‐Da Yu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 67
LncRNA HOTAIR: A Potential Prognostic Factor and Therapeutic Target in Human Cancers
Xiaoru Xin, Qianan Li, Jinyong Fang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 56
EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer
Y. Chen, Hongyan Zhu, Yi Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116624-116624
Open Access | Times Cited: 8
LncRNA HOTAIR enhances breast cancer radioresistance through facilitating HSPA1A expression via sequestering miR‐449b‐5p
Shuqin Zhang, Bin Wang, Huiwen Xiao, et al.
Thoracic Cancer (2020) Vol. 11, Iss. 7, pp. 1801-1816
Open Access | Times Cited: 66
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
Elham Sajjadi, Konstantinos Venetis, Roberto Piciotti, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 42
Integrating single cell sequencing with a spatial quantitative systems pharmacology model spQSP for personalized prediction of triple-negative breast cancer immunotherapy response
Shuming Zhang, Chang Gong, Álvaro Ruiz-Martínez, et al.
ImmunoInformatics (2021) Vol. 1-2, pp. 100002-100002
Open Access | Times Cited: 30
Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer
Kassidy M. Jungles, Erin A. Holcomb, Ashley N. Pearson, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma
Camilla Palumbo, Monica Benvenuto, Chiara Focaccetti, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials
Rama Rao Malla, Mundla Srilatha, Veda Muppala, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 707-720
Closed Access | Times Cited: 4
Novel antibody cocktail therapy targeting extracellular tumor-specific mutations to treat triple-negative breast cancer
Stephanie C. Pero, Girja S. Shukla, Yujing Sun, et al.
Research Square (Research Square) (2025)
Closed Access
Expression of four cancer-testis antigens in TNBC indicating potential universal immunotherapeutic targets
Jie Xiao, Fengli Huang, Lin Li, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 16, pp. 15003-15011
Open Access | Times Cited: 9
On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy
Sai Mummareddy, Stuti Pradhan, Ashwin Kumar Narasimhan, et al.
Biosensors (2021) Vol. 11, Iss. 12, pp. 500-500
Open Access | Times Cited: 21
Single-cell RNA reveals a tumorigenic microenvironment in the interface zone of human breast tumors
Wei Yang, Meiyu Xu, Shuoqi Xu, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Reviewing the significance of dendritic cell vaccines in interrupting breast cancer development
Namrata Gautam, Ganesan Ramamoorthi, Nicholas Champion, et al.
Molecular Aspects of Medicine (2023) Vol. 95, pp. 101239-101239
Closed Access | Times Cited: 9
Breast cancer vaccination: Latest advances with an analytical focus on clinical trials
Mahdi Kohansal Vajari, Mohammad‐Javad Sanaei, Sina Salari, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110696-110696
Closed Access | Times Cited: 8
Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer
Lei Zhu, Yanmei Wu, Haichun Zhao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Targeting Neoantigens in Cancer: Possibilities and Opportunities in Breast Cancer
Zuhair Chaudhry, Anik Boyadzhyan, Kayvan Sasaninia, et al.
Antibodies (2024) Vol. 13, Iss. 2, pp. 46-46
Open Access | Times Cited: 2
Obesity as a Risk Factor for Breast Cancer—The Role of miRNA
Karolina Hanusek, Jakub Karczmarski, Anna Litwiniuk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15683-15683
Open Access | Times Cited: 11
Circ_0008500 Knockdown Improves Radiosensitivity and Inhibits Tumorigenesis in Breast Cancer Through the miR-758-3p/PFN2 Axis
Deyou Kong, Dongxing Shen, Zhikun Liu, et al.
Journal of Mammary Gland Biology and Neoplasia (2022) Vol. 27, Iss. 1, pp. 37-52
Closed Access | Times Cited: 9
MiR-1270 Suppresses the Malignant Progression of Breast Cancer via Targeting MMD2
Shaojun Hu, Yang Song, Yu Zhou, et al.
Journal of Healthcare Engineering (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top